Trial intelligence / Profile preview

Exenatide vs Metformin vs Combination in PCOS

NCT00344851Phase 2Completed

Sponsor
Metabolic Center of Louisiana Research Foundation
Start
Jun 2006
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of exenatide in polycystic ovary syndrome (PCOS), sponsored by Metabolic Center of Louisiana Research Foundation. Started Jun 2006; status: completed.

02

Drugs

exenatide
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT00344851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00344851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call